142 related articles for article (PubMed ID: 9074796)
1. Hemin-induced erythroid differentiation of human myeloleukemia K562 cell line and its modification by bioresponse modifiers.
Nakajima O; Iwasaki S; Hashimoto Y
Cell Mol Biol (Noisy-le-grand); 1997 Feb; 43(1):115-34. PubMed ID: 9074796
[TBL] [Abstract][Full Text] [Related]
2. [Chemical control of cell differentiation of human myeloleukemia K562 cell line].
Koiso Y; Nakajima O; Matsumura D; Fujimoto Y; Hashimoto Y
Yakugaku Zasshi; 2000 Jan; 120(1):104-12. PubMed ID: 10655786
[TBL] [Abstract][Full Text] [Related]
3. Possible involvement of retinoid-like cofactor in serum in hemin/protoporphyrin-IX-induced differentiation of human leukemia K562 cells.
Nakajima O; Kagechika H; Shudo K; Hashimoto Y; Iwasaki S
Biochem Biophys Res Commun; 1995 Jan; 206(3):1003-10. PubMed ID: 7832789
[TBL] [Abstract][Full Text] [Related]
4. Erythroid differentiation-inducing activity of protoporphyrin IX and its analogs on human leukemia K562 cell line.
Nakajima O; Hashimoto Y; Iwasaki S
Biochem Biophys Res Commun; 1994 Jan; 198(2):720-7. PubMed ID: 8297384
[TBL] [Abstract][Full Text] [Related]
5. Possible involvement of peripheral-type benzodiazepine receptors in erythroid differentiation of human leukemia cell line, K562.
Nakajima O; Hashimoto Y; Iwasaki S
Biol Pharm Bull; 1995 Jun; 18(6):903-6. PubMed ID: 7550130
[TBL] [Abstract][Full Text] [Related]
6. Enhancement by retinoid of hemin-induced differentiation of human leukemia K562 cell line.
Nakajima O; Hashimoto Y; Iwasaki S
FEBS Lett; 1993 Sep; 330(1):81-4. PubMed ID: 8370465
[TBL] [Abstract][Full Text] [Related]
7. Effects of the antisense myb expression on hemin- and erythropoietin-induced erythroid differentiation of K562 cells.
Kamano H; Tanaka T; Ohnishi H; Kubota Y; Ikeda K; Takahara J; Irino S; Ottalenghi S
Biochem Mol Biol Int; 1994 Aug; 34(1):85-92. PubMed ID: 7849628
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of erythroid differentiation by stem cell factor in K562 cells expressing the c-kit gene.
Ogawa K; Tashima M; Toi T; Sawai H; Sawada H; Fujita J; Maruyama Y; Okuma M
Exp Hematol; 1994 Jan; 22(1):45-51. PubMed ID: 7506674
[TBL] [Abstract][Full Text] [Related]
9. Enhancement by hemin of the sensitivity of K562 human leukemic cells to 1-beta-D-arabinofuranosylcytosine.
Okabe-Kado J; Hayashi M; Honma Y; Hozumi M
Cancer Res; 1986 Mar; 46(3):1239-43. PubMed ID: 3455882
[TBL] [Abstract][Full Text] [Related]
10. ETS-1 induces increased expression of erythroid markers in the pluripotent erythroleukemic cell lines K562 and HEL.
Clausen PA; Athanasiou M; Chen Z; Dunn KJ; Zhang Q; Lautenberger JA; Mavrothalassitis G; Blair DG
Leukemia; 1997 Aug; 11(8):1224-33. PubMed ID: 9264374
[TBL] [Abstract][Full Text] [Related]
11. Iron protoporphyrin IX (hemin) but not tin or zinc protoporphyrin IX can stimulate gene expression in K562 cells from enhancer elements containing binding sites for NF-E2.
Palma JF; Gao X; Lin CH; Wu S; Solomon WB
Blood; 1994 Aug; 84(4):1288-97. PubMed ID: 8049443
[TBL] [Abstract][Full Text] [Related]
12. Hemin-induced erythroid differentiation changes the sensitivity of K562 cells to tumor necrosis factor-alpha.
Li XF; Anderson J; Hutzler D; Roodman GD
Exp Hematol; 1989 Dec; 17(11):1059-62. PubMed ID: 2555212
[TBL] [Abstract][Full Text] [Related]
13. A high concentration of triiodothyronine attenuates the stimulatory effect on hemin-induced erythroid differentiation of human erythroleukemia K562 cells.
Shiraishi M; Yamamoto Y; Hirooka N; Obuchi Y; Tachibana S; Makishima M; Tanaka Y
Endocr J; 2015; 62(5):431-40. PubMed ID: 25787723
[TBL] [Abstract][Full Text] [Related]
14. Effect of differentiation-inducing agents on oncogene expression in a chronic myelogenous leukemia cell line.
Eisbruch A; Blick M; Evinger-Hodges MJ; Beran M; Andersson B; Gutterman JU; Kurzrock R
Cancer; 1988 Sep; 62(6):1171-8. PubMed ID: 3044574
[TBL] [Abstract][Full Text] [Related]
15. Modification by heme oxygenase inhibitor, tin protoporphyrin, of cellular differentiation of human myeloid leukemia K562 cell line.
Koiso Y; Fujimoto Y; Matsumura D; Nakajima O; Hashimoto Y
Biol Pharm Bull; 1999 Apr; 22(4):439-40. PubMed ID: 10328571
[TBL] [Abstract][Full Text] [Related]
16. Increase in the chemically-induced differentiation of human leukemia cell lines by tubulin disruptors.
Nakajima O; Sugishita Y; Hashimoto Y; Iwasaki S
Biol Pharm Bull; 1994 May; 17(5):742-4. PubMed ID: 7920447
[TBL] [Abstract][Full Text] [Related]
17. Protoporphyrin IX regulates peripheral benzodiazepine receptor associated protein 7 (PAP7) and divalent metal transporter 1 (DMT1) in K562 cells.
Okazaki Y; Glass J
Biochem Biophys Rep; 2017 Jul; 10():26-31. PubMed ID: 28955733
[TBL] [Abstract][Full Text] [Related]
18. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
Ray S; Bullock G; Nuñez G; Tang C; Ibrado AM; Huang Y; Bhalla K
Cell Growth Differ; 1996 Dec; 7(12):1617-23. PubMed ID: 8959329
[TBL] [Abstract][Full Text] [Related]
19. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers.
Chen YL; Wu RT
Cancer Res; 1994 Apr; 54(8):2192-8. PubMed ID: 7513611
[TBL] [Abstract][Full Text] [Related]
20. Induction to erythroid differentiation of K562 cells by 1-beta-D-arabinofuranosylcytosine is inhibited by iron chelators: reversion by treatment with hemin.
Feriotto G; Nastruzzi C; Barbieri R; Gambari R
Blut; 1988 Jul; 57(1):25-30. PubMed ID: 3164639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
